Conference Programme

 Save and Print Conference Program

Last Update: 03 November 2012


TIME DAY 1 - 06 NOVEMBER 2012 (TUESDAY)
BIOMALAYSIA 2012 - DRIVING INNOVATION AND WEALTH CREATION THROUGH BIOECONOMY
9.00 am PLENARY : Bioeconomy in Action: Its Impact and Opportunities for Asia

CHAIRPERSON
Ybhg. Prof. Dr. Rofina Yasmin Othman, Professor, University of Malaya, Malaysia

SPEAKERS
Dr. Regis B. Kelly, University of California, USA
Alexandre Jetzer-Chung (IAP), Member Emeritus of the Board of Directors, Novartis AG, Switzerland
Dr. Kenichi Arai, University of Tokyo, Japan
Dr. Roger Wyse, Co-Chairman / Director, Malaysia Life Sciences Capital Fund, Malaysia
Dato' Dr Mohd Nazlee Kamal, CEO, BiotechCorp, Malaysia
10.40 am Tea Break
11.00 am PLENARY : Bioeconomy in Economic Corridors

CHAIRPERSON
Dr Abdul Manaf Mohd Radzi, Senior Vice President, Special Project, BiotechCorp, Malaysia

SPEAKERS
Dato' Redza Rafiq, Northern Corridor Implementation Authority (NCIA), Malaysia
Dato' Jebasingam Issace John, East Coast Economic Region (ECER) Development Council, Malaysia
Datuk Dr. Yaakub Hj Johari, Sabah Economic Development and Investment Authority (SEDIA), Malaysia
YM Raja Taufiq,Iskandar Regional Development Authority (IRDA), Malaysia
12.30 pm PLENARY : National Biomass Strategy 2020, Progress One Year On

Bas Melssen
Executive Vice President and Head, Strategic Impact-Wealth Creation, Agensi Inovasi Malaysia, Malaysia
12.45 pm PLENARY: MyBiomass : A Special Purpose Vehicle Of The Malaysian Biomass Initiative (MBI)

R. Puvaneswari
Managing Director, MyBioMass, Malaysia
1.00 pm Lunch
2.30 pm PLENARY - Theme: Innovate Now! Whatever it Takes... (together with WIF-KL 2012) at Plenary Hall

CHAIRPERSON
Rohit Shukla, CEO, Larta Institute, California

SPEAKERS
James A. Hayward, Chairman, President and CEO, DNA Sciences, USA
Dr. Khalid M Al-Ruwaihi, DG of External Relations, Centres of Excellence, University of Bahrain, Bahrain
Prof. Noboru Konno, President, Knowledge Innovation research Organization, Japan
INNOVATION COMMERCIALISATION
Track 1: Innovation as the Foundation for Bioeconomy Track 2: Developing Strategic Co-operation for Bioeconomy
3.30 pm CHAIRPERSON
Dr. Wan Abdul Rahaman Wan Yaacob
Advisor, Biotechnology Initiatives, Manufacturing Division, Northern Corridor Implementation Authority, Malaysia
CHAIRPERSON
John Low
Partner, Roland Berger Strategy Consultants Sdn Bhd, Malaysia
  1. Role of Biocontrols and Biofertilizers for Safe Ecofriendly Agriculture
    Dr. S. Ramarethinam

    President/R&D and Projects, T. Stanes and Company Limited, India

  2. Transforming the Economics of Drug Discovery. Letting Software make the Decisions
    Prof. Dr. David Leahy

    Founder & CEO, Molplex, United Kingdom

  3. Unravelling The Potential of Leucaena leucocephala: The Nu-Age Petroleum for Global White Biotechnology Industry
    Dr. Kannika Rengsirikul
    Lecturer, Valaya Alongkorn Rajabhat University, Thailand

  4. Advanced Purification Technologies For Bio-Based Chemicals
    Thibault LeSaffre
    Bioindustries Market Director, Novasep, France
  1. Creating a Vibrant Biotechnology Park and Ecosystem to Nurture theBioeconomy: Role of Strategic Partnerships
    Rizatuddin Ramli
    Chief Executive Officer, Malaysian Bio-XCell Sdn. Bhd, Malaysia

  2. Innovative Molecular Screening and Public Health, a Novel Cornerstone for Malaysia's Healthcare Bioeconomy?
    Dr. Stephen Rudd
    Chief Scientific Officer, MGRC, Malaysia

  3. Building Canadian Bioindustrial Clusters – A Model
    Dr. Murray McLaughlin
    Executive Director Bioindustrial Innovation Centre, Canada

  4. Topic TBC
    En. A Aziz Othman
    Head, Strategic Planning & Business Development, Petronas Chemical Group, France
5.30 pm Welcome / Networking Reception at BioMalaysia Exhibition (Hall 1 – 3)
TIME DAY 2 - 07 NOVEMBER 2012 (WEDNESDAY)
Track 3: Building the Value Chain for Bioeconomy - Healthcare (ISPE) Track 4: Natural Substances - From Scientific Discovery to Market Success
9.00 am CHAIRPERSON
Jay Padasian
Senior Vice President Healthcare, BiotechCorp, Malaysia
CHAIRPERSON
Dr. Francesca Blasco
Director, Pharmacology, Novartis Institute For Tropical Diseases, Singapore
  1. Translating the Vision of Biosimilars to Reality
    Ibrahim Zainudin
    COO, CCM Pharmaceuticals, Malaysia

  2. The Utilization Value of Emerging Manufacturing Technologies
    Prof. Dr. Jaeseung Yoon
    CEO Pangen Biotech, Korea

  3. Current Market Overview in Injectables Technology Landscape / Global Trends and Advances in Biopharmaceutical Manufacturing
    Mr. Raman Srinivasan
    Head of Biologics Manufacturing, Biocon, India

  1. Key Address and Opening by Avinash Potnis
    Executive Officer, Novartis Corporation (Malaysia) Sdn Bhd, Malaysia

  2. Introduction by Alexandre Jetzer-Chung
    Member Emeritus of the Board of Directors, Novartis AG, Switzerland

  3. Biological Diversity and its Role as a Driving Force For The Development Of New Drugs
    Dr. Frank Petersen
    Executive Director Natural Products Unit, Novartis, Switzerland

  4. Natural Product Research as Innovative Source for New Medications
    Dr. Philipp Krastel
    Group Leader Natural Products Unit, Novartis, Switzerland
10.15 am Tea Break
Track 3: Building the Value Chain for Bioeconomy - Agriculture Track 4: Natural Substances - From Scientific Discovery to Market Success
10.30 am CHAIRPERSON
Dr. Kodi Isparan Kandasamy
Senior Vice President Agriculture, BiotechCorp, Malaysia
CHAIRPERSON
Dr. Francesca Blasco
Director, Pharmacology, Novartis Institute For Tropical Diseases, Singapore
  1. Biochemistry of Love: Biotechnology Advances in Cultivated Cordyceps & Formulation
    Dato' Chang Eng Thuan
    Technical Director, BioFact Life Sdn Bhd, Malaysia

  2. Metabolic Innovations Using Redox Biology for Agricultural and Food Biotechnology Applications
    Prof. Dr. Kalidas Shetty
    University of Massachusetts Amherst (UMASS), USA

  3. Global Cooperation: A Case Study on Aquaculture Value Chain : Darden-Evernexus partnership
    Dr. Shahridan Faiez
    Principal, Darden-Evernexus, Malaysia
  1. Discovery and Development of Novel Antimalarial Drugs for the Treatment of P. Falciparum and P. Vivax Malaria
    Dr. Bryan K. S. Yeung
    Associate Director for Malaria Programme, Novartis Institute of Tropical Diseases, Singapore

  2. Building a Discovery Partnership with a Major Pharma: the Novartis and Sarawak Biodiversity Centre Collaboration on Microbial Discoveries
    Dr. Charlie Yeo Tiong Chia
    Senior Research Officer, Sarawak Biodiversity Centre, Malaysia
Track 3: Building the Value Chain for Bioeconomy - Industrial Track 4: Market Success and Financing Biotech
11.45 am CHAIRPERSON
Zainal Azman
Senior Vice President Industrial, BiotechCorp, Malaysia
CHAIRPERSON
Dr. Francesca Blasco
Director, Pharmacology, Novartis Institute For Tropical Diseases, Singapore
  1. Biorefinery Technology for Sustainable Production of Industrial Biochemical
    M. Johan De Coninck
    IAR Cluster, France

  2. The Greenfield Biorefinery Opportunity: Real or Myth P.I.V.E.R.T., a French PPP to Develop the Oil-Based Biorefinery
    Mr. Jean François Rous
    Corporate Innovation Director, Sofiproteol, France

  3. DuPont Biofuels: Driving the Biobased Economy
    Ir. Floris Luger
    Vice President of Business Development, Dupont Industrial Biosciences, France

  4. Biorefinery and Challenges of Bioeconomy in Europe
    Mr. Christophe Luguel
    Head of International Affairs, IAR Cluster, France

  5. Complete Utilization of Lignocellulose: Refining Concept for Palm Empty Fruit Bunch
    Gilles Amsallem
    CEO, Biométhodes, France
  1. Introduction by Dr. Shahnaz Murad
    Director, Institute for Medical Research, Malaysia

  2. Accelerating The Critical Path From Discovery To Market Success
    Alexandre Jetzer-Chung (IAP)
    Member Emeritus of the Board of Directors, Novartis AG, Switzerland

  3. Investing in Lnnovative Life Science Companies for Patient Benefit Creating Attractive Returns for Entrepreneurs and Investors
    Dr. Reinhard Ambros
    Executive Director, Novartis Venture Funds, Switzerland
1.00 pm Lunch
Track 5: Enablers to Drive a Bioeconomy Track 6: Sustainable Growth through Successful Commercialisation
2.00 pm CHAIRPERSON
Prof. Dr. Zainul Fadziruddin
Director Business Advisory Division, Malaysian Technology Development Corporation Sdn. Bhd., Malaysia
CHAIRPERSON
Rohit Shukla
CEO, Larta Institute, California
  1. Managing Talent and Human Capital
    Kenny Ong Chun Eng
    Senior Vice President, Takaful Ikhlas Sdn Bhd (TISB), Malaysia

  2. Developing Funding Schemes to Support Innovative, High-Impact Technologies
    Datuk Md. Zubir Ansori,
    CEO, MDV, Malaysia

  3. Malaysia - A Strategy for Building Asian Beach Head for Innovation Start-Ups in the Ag Tech Sector
    Mr. Arama Kukutai
    Managing Director, Finistere Ventures LLC, USA

  4. IP Policy for the Biotechnology Century
    Aaron Smethurst
    Director, International (Multilateral) Global Intellectual Property Center, U.S. Chamber of Commerce

  5. Enablers of Biosimilars to Drive Bioeconomy
    Dr. Karthik Ramani
    Senior Scientific Manager/Group Leader Biologics Formulation, R&D Biocon Research Limited, Biocon, India
  1. Sustainable Growth Through Successful Commercialization Of Stevia Cultivation
    Dr. Sharifah Sabrina
    CEO, BNG Global Holding, Malaysia

  2. Tapping the Microbiome for Commercial and Sustainable Applications
    Dr. Chia Boon Tat
    Chief Executive Officer, Interactive Micro-Organisms Laboratories Pte Ltd, Singapore

  3. Biosimilars
    Prof. Dr. Jaeseung Yoon
    CEO, Pangen Biotech, Korea

  4. Cell Therapy for the Musculo-Skeletal System
    Dr. Saw Khay Yong
    Founder/Senior Partner of Kuala Lumpur Sports Medicine Centre, Malaysia
4.15 pm Tea Break
4.30 pm CHAIRPERSON
Prof. Dato’ Dr. Mohamed Isa
Chief Executive Officer, National Institutes of Biotechnology Malaysia (NIBM), Malaysia
Panel Discussion:
The Future of Bioeconomy: Opportunities and Challenges

Mr. Arama Kukutai, Managing Director, Finistere Ventures LLC, USA
Dr. Arif Anwar, Executive Director, Sengenics
Kelvin Soo, Furley Bioextracts Sdn Bhd, Malaysia
Mr. Iqbal Huq, Managing Director, Cardia Bioplastics Malaysia Sdn Bhd, Malaysia
Aaron Smethurst, Director, International (Multilateral) Global Intellectual Property Center, U.S. Chamber of Commerce
5.30 pm End of Conference Day 2

Conference Program Disclaimer:
This Conference Program is correct at the time of print. However, the Organizer reserves the right to make changes at any time.
Enquiries: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

You are here Conference Conference Programme